The effects of a platelet activating factor antagonist on the respiratory, myocardial and cerebral consequences of cardiopulmonary bypass and further observations on cardiac surgery without cardiopulmonary bypass
Main Author: | Taggart, David Paul |
---|---|
Published: |
University of Strathclyde
2000
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.248531 |
Similar Items
-
Features of Cardiopulmonary Bypass in Mininvasive Multivessel Coronary Artery Bypass Grafting
by: V. M. Demianenko, et al.
Published: (2019-05-01) -
Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol
by: M.J.C. Carmona, et al.
Published: (2009-06-01) -
A Comparation of Coronary Artery Bypass Grafting with and without Cardiopulmonary Bypass in Euroscore High Risk Patients
by: Emir Kabil, et al.
Published: (2007-02-01) -
Effect of ischemic postconditioning on myocardial protection in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass
by: Nasser Safaei, et al.
Published: (2016-06-01) -
Computed tomography assessment of lung structure in patients undergoing cardiac surgery with cardiopulmonary bypass
by: R.R. Rodrigues, et al.
Published: (2011-06-01)